Abstract
Chemotherapy-induced alopecia is the most common side effect of medication. This phenomenon is a common patient complaint and a source of significant psychological and physical distress. A major challenge in treating chemotherapy-induced alopecia is to protect the hair without altering the effects of the chemotherapeutic treatment regimen. The search for compounds that can significantly reduce or block damage to the hair follicle by chemotherapeutic agents is an active and dynamic area of research. At present, there are no FDA-approved treatments or preventative measures for chemotherapy-induced alopecia. To address this problem, a variety of new agents have emerged in patent applications. This report reviews 19 patents that have been submitted since 2000 for the treatment or prevention of chemotherapy-induced alopecia.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
